Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL von Sandhu, Karamjeet S., Macias, Alan, Del Real, Marissa, Beltran, Asuscena L., Kim, Young Sun, Zhang, Jianying, Palmer, Joycelynne, Robbins, Marjorie, Loomis, Reyna, Akhtari, Mojtaba, Aribi, Ahmed, Arslan, Shukaib, Salhotra, Amandeep, Mei, Matthew, Pourhassan, Hoda, Koller, Paul B., Amanam, Idoroenyi, Agrawal, Vaibhav, Curtin, Peter T., Spielberger, Ricardo, Pullarkat, Vinod A., Aldoss, Ibrahim, Stewart, F. Mark, Smith, Eileen P., Forman, Stephen J, Stein, Anthony S., Marcucci, Guido, Budde, L. Elizabeth

Volltext